ATP-binding cassette transporter A1 locus is not a major determinant of HDL-C levels in a population at high risk for coronary heart disease

Atherosclerosis

Volumn 166, Issue 2, 2003, Pages 285-290

  Kakko, Sakari ^a   Kelloniemi, Jani ^a   Von Rohr, Peter ^b   Hoeschele, Ina ^b   Tamminen, Minna ^a   Brousseau, Margaret E ^c   Kesäniemi, Y Antero ^a   Savolainen, Markku J ^a  

^a UNIVERSITY OF OULU   (Finland)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^c TUFTS UNIVERSITY   (United States)

Author keywords

Coronary heart disease; Genetic; Genetic polymorphisms; High density lipoproteins; Quantitative trait locus

Indexed keywords

ABC TRANSPORTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FINLAND; GENE FUNCTION; GENE LOCUS; GENE MUTATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SCREENING; GENOTYPE; HUMAN; HYPOLIPOPROTEINEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE TRAIT LOCUS;

ADULT; ANALYSIS OF VARIANCE; ATP-BINDING CASSETTE TRANSPORTERS; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CORONARY DISEASE; FEMALE; FINLAND; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; PROBABILITY; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0037298521     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00232-0     Document Type: Article

References (31)

1. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease. Am. J. Med. 62:1977;707-714.
2. Genest J.J. Jr, Martin-Munley S.S., McNamara J.R., et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation. 85:1992;2025-2033.
3. Almasy L., Hixson J.E., Rainwater D.L., et al. Human pedigree-based quantitative-trait-locus mapping: localization of two genes influencing HDL-cholesterol metabolism. Am. J. Hum. Genet. 64:1999;1686-1693.
4. Peacock J.M., Arnett D.K., Atwood L.D., et al. Genome scan for quantitative trait loci linked to high-density lipoprotein cholesterol: The NHLBI Family Heart Study. Arterioscler. Thromb. Vasc. Biol. 21:2001;1823-1828.
5. Arya R., Duggirala R., Almasy L., et al. Linkage of high-density lipoprotein-cholesterol concentrations to a locus on chromosome 9p in Mexican Americans. Nat. Genet. 30:2001;102-105.
6. Kort E.N., Ballinger D.G., Ding W., et al. Evidence of linkage of familial hypoalphalipoproteinemia to a novel locus on chromosome 11q23. Am. J. Hum. Genet. 66:2000;1845-1856.
7. Coon H., Leppert M.F., Eckfeldt J.H., et al. Genome-wide linkage analysis of lipids in the Hypertension Genetic Epidemiology Network (HyperGEN) Blood Pressure Study. Arterioscler. Thromb. Vasc. Biol. 21:2001;1969-1976.
8. Imperatore G., Knowler W.C., Pettitt D.J., Kobes S., Fuller J.H., Bennett P.H., Hanson R.L. A locus influencing total serum cholesterol on chromosome 19p: results from an autosomal genomic scan of serum lipid concentrations in Pima Indians. Arterioscler. Thromb. Vasc. Biol. 20:2000;2651-2656.
9. Soro A., Pajukanta P., Lilja H.E., et al. Genome scans provide evidence for low-HDL-C loci on chromosomes 8q23, 16q24.1-24.2, and 20q13.11 in Finnish families. Am. J. Hum. Genet. 70:2002;1333-1340.
10. Inazu A., Jiang X.C., Haraki T., et al. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J. Clin. Invest. 94:1994;1872-1882.
11. Franceschini G. Apolipoprotein function in health and disease: insights from natural mutations. Eur. J. Clin. Invest. 26:1996;733-746.
12. Kuivenhoven J.A., Pritchard H., Hill J., Frohlich J., Assmann G., Kastelein J. The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J. Lipid Res. 38:1997;191-205.
13. Fisher R.M., Humphries S.E., Talmud P.J. Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis. Atherosclerosis. 135:1997;145-159.
14. Guerra R., Wang J., Grundy S.M., Cohen J.C. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc. Natl. Acad. Sci. USA. 94:1997;4532-4537.
15. Oram J.F., Lawn R.M. ABCA1. The gatekeeper for eliminating excess tissue cholesterol. J. Lipid Res. 42:2001;1173-1179.
16. Brooks-Wilson A., Marcil M., Clee S.M., et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22:1999;336-345.
17. Bodzioch M., Orso E., Klucken J., et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22:1999;347-351.
18. Rust S., Rosier M., Funke H., et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22:1999;352-355.
19. Marcil M., Brooks-Wilson A., Clee S.M., et al. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet. 354:1999;1341-1346.
20. Brousseau M.E., Schaefer E.J., Dupuis J., et al. Novel mutations in the gene encoding ATP-binding cassette 1 in four Tangier disease kindreds. J. Lipid Res. 41:2000;433-441.
21. Wang J., Burnett J.R., Near S., et al. Common and rare ABCA1 variants affecting plasma HDL cholesterol. Arterioscler. Thromb. Vasc. Biol. 20:2000;1983-1989.
22. Clee S.M., Zwinderman A.H., Engert J.C., et al. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation. 103:2001;1198-1205.
23. Brousseau M.E., Bodzioch M., Schaefer E.J., et al. Common variants in the gene encoding ATP-binding cassette transporter 1 in men with low HDL cholesterol levels and coronary heart disease. Atherosclerosis. 154:2001;607-611.
24. Lutucuta S., Ballantyne C.M., Elghannam H., Gotto A.M. Jr, Marian A.J. Novel polymorphisms in promoter region of ATP binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ. Res. 88:2001;969-973.
25. Rantala A.O., Kauma H., Lilja M., Savolainen M.J., Reunanen A., Kesäniemi Y.A. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J. Intern. Med. 245:1999;163-174.
26. Kakko S., Tamminen M., Kesäniemi Y.A., Savolainen M.J. R451Q mutation in the cholesteryl ester transfer protein (CETP) gene is associated with high plasma CETP activity. Atherosclerosis. 136:1998;233-240.
27. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
28. Almasy L., Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am. J. Hum. Genet. 62:1998;1198-1211.
29. Campbell M.J., Julious S.A., Altman D.G. Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. Biol. Med. J. 311:1995;1145-1148.
30. Lander E., Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11:1995;241-247.
31. Breslow J.L. Familial disorders of high-density lipoprotein metabolism. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The metabolic and molecular bases of inherited disease. 1995;2031-2052 McGraw-Hill, New York.